ICPOC 2026

Refine the list (min. 2 characters)

Keynote Presentation (In-Person)

Thomas J. Webster, Speaker at Cancer Science and Research Conference

Title: Anti-cancer nanomedicine in humans: A review and future directions

This presentation will cover a close to 30 year journey researching and commercializing nanotechnology for improving disease prevention, diagnosis, and treatment (including cancer) which has led to numerous products including nano spinal implants now in over 30,000 patients to da [....] » Read More

Thomas J. Webster, Brown University, United States

Keynote Presentation (In-Person)

Sergey Suchkov, Speaker at Cancer Science and Research Conference

Title: Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: an option for clinical oncologists, caregiv-ers and consumers to secure the human biosafety

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). Meanwhile, the era of genomics-based medicine and thus genomics biomarkers promises to provide molecular tests that will pe [....] » Read More

Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Oral Presentation (In-Person)

Sergey Suchkov, Speaker at Cancer Science and Research Conference

Title: Precision oncology strategy for cancer care team: Developing targeted cancer therapy & advancing personalized cancer

A comprehensive molecular tumor analysis integrating a combination of NGS methods including whole-exome (WES), whole-genome (WGS) and transcriptome sequencing (RNAseq) offers the best chance for personalizing cancer care, enlarging the scope of therapy choices and offering potent [....] » Read More

Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Oral Presentation (In-Person)

Sebastiano Venturi, Speaker at Oncology Conference

Title: Iodine and Caesium-137: Angels and Demons of evolutionary Biology, in Pancreatic Cancer and Diabetes

The Chernobyl nuclear accident, on 1986, marked a turning point in both the history of energy production and our understanding of the relationship between human technology and life. J.R. Oppenheimer evoked the famous Hindu scripture, “Now I am become Death, the&nb [....] » Read More

Sebastiano Venturi, Department of Public Health of Rimini, Italy

Oral Presentation (In-Person)

Shanza Waseem, Speaker at Cancer Science and Research Conference

Title: Precision Oncology in Gynecologic Cancers: Molecular Taxonomy, Biomarker-Guided Therapeutics, and the Challenge of Therapeutic Resistance

Background: The clinical management of gynecologic malignancies—endometrial (EC), ovarian (OC), and cervical (CC) carcinomas—has been historically guided by histomorphology and staging. This paradigm fails to capture profound molecular heterogeneity, resulting in [....] » Read More

Shanza Waseem, Sichuan University, China

Keynote Presentation (Virtual)

Paulo Cesar De Morais, Speaker at Oncology Conference

Title: Prospecting fluorine-doped graphene in photodynamic therapy

Halogen-decorated graphene quantum dots (X@GQDs) will be herein explored as a material platform for application in photodynamic therapy (PDT). GQDs have been extensively studied in biomedical areas such as bioimaging, bio-sensing and photothermal therapy due to their superior opt [....] » Read More

Paulo Cesar De Morais, Catholic University of Brasilia, Brazil

Oral Presentation (Virtual)

Tanja Obradovic, Speaker at Cancer Conferences

Title: How to chose right Clinical Research Organization (CRO) partner when developing new cancer drug while meeting challenges of current critical trends in oncology drug development?

During the last decade there have been major breakthroughs in cancer treatment options driven by immunotherapy and most recently cell and gene products. With increased number of new cancer drug candidates entering clinical development there is elevated need for identification of [....] » Read More

Tanja Obradovic, Arc Nouvel LLC, United States

Oral Presentation (Virtual)

Yacob mathai Kunnathazhath, Speaker at Cancer Science and Research Conference

Title: A new Universal Fever Definition and the unscientific nature of the conservative fever definition.

No medical textbook tells us what the purpose of fever is. Without knowing this, no one in the world can define, test, or treat fever. The current definition, testing, and treatment of fever, which is constructed without knowing what the purpose of fever is, has no scientific bas [....] » Read More

Yacob mathai Kunnathazhath, Marma Health Centre, India

Poster Presentation (Virtual)

Abir Biswas, Speaker at Oncology Conference

Title: Effect of Posaconazole Compared to Other Antifungal Drugs in Survival & Prevention of Infection in Patients with Haematological Malignancy: A Systematic Review

Background: Patients with acute leukemia who experience neutropenia after intensive chemotherapy have a high risk of developing Invasive Fungal Infections (IFIs), which can be life threatening. Although diagnostics and supportive care have been enhanced, IFIs continue to be a maj [....] » Read More

Abir Biswas, Sher-E- Bangla Medical College, Bangladesh
To be updated shortly...

Copyright 2024 Mathews International LLC All Rights Reserved

Watsapp
Top